Whole blood over-represented pathways were most robust at 0–24 h after stroke, and rather than being related to cytokines or chemokines, they appear to relate to specific biological responses to ischemia including p53, ATM, cAMPact, and AMP-activated protein kinase signaling [72–77]. This evidence concerns the gene TP53 and stroke disorder.